Naproxen and piroxicam. A comparative trial in rheumatoid arthritis
- PMID: 6239778
Naproxen and piroxicam. A comparative trial in rheumatoid arthritis
Abstract
A single-blind crossover trial in 60 patients with rheumatoid arthritis showed that piroxicam, 20 mg daily and naproxen, 500 mg twice daily were comparable in both efficacy and tolerance.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical